However, as neprilysin inhibitors have been combined successfully with ARBs in the treatment of cardiovascular diseases and with promising prospects in diabetic nephropathy 8–10,19, we treated our rat model also with a combination of NPR3i and ARB. This evidence concerns the gene MME and diabetic kidney disease.